FORM 6-K
 
 
SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549
 
 
Report of Foreign Issuer
 
 
Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934
 
 
 
For period ending 11 May 2017
 
GlaxoSmithKline plc
(Name of registrant)

 
 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)

 
 
 
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F

 
 
 
Form 20-F x     Form 40-F

 
--

 
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.

 
 
 
Yes      No x
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
 
Date: 12 May 2017
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
GlaxoSmithKline Share Option Plan - Ordinary Shares
 
Period of return:
 
From:
 
1 November 2016
 
To:
 
30 April 2017
 
Balance of unallotted securities under scheme(s) from previous return:
 
3,530,802
 
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
2,142,9521
 
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
1,569,653
 
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
 
4,104,101
 
1 This figure includes an adjustment of +142,952 unallotted securities that were allotted under the GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan but originally debited from the balance for this Scheme.
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
 
Date: 12 May 2017
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
GlaxoSmithKline Share Option Plan - ADS
 
Period of return:
 
From:
 
1 November 2016
 
To:
 
30 April 2017
 
Balance of unallotted securities under scheme(s) from previous return:
 
9,349,738
 
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
553,924
 
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
 
8,795,814
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
 
Date: 12 May 2017
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
Glaxo Wellcome UK Share Option Scheme
 
Period of return:
 
From:
 
1 November 2016
 
To:
 
30 April 2017
 
Balance of unallotted securities under scheme(s) from previous return:
 
5,119,750
 
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
0
 
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
 
5,119,750
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
 
Date: 12 May 2017
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
Glaxo Wellcome International Share Option Scheme
 
Period of return:
 
From:
 
1 November 2016
 
To:
 
30 April 2017
 
Balance of unallotted securities under scheme(s) from previous return:
 
13,267,156
 
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
0
 
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
 
13,267,156
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
 
Date: 12 May 2017
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
Glaxo Wellcome 1999 Share Option Plan
 
Period of return:
 
From:
 
1 November 2016
 
To:
 
30 April 2017
 
Balance of unallotted securities under scheme(s) from previous return:
 
1,040,000
 
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
0
 
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
 
1,040,000
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
 
Date: 12 May 2017
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares
 
Period of return:
 
From:
 
1 November 2016
 
To:
 
30 April 2017
 
Balance of unallotted securities under scheme(s) from previous return:
 
163,606
 
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
0
 
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
 
163,606
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
 
Date: 12 May 2017
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS
 
Period of return:
 
From:
 
1 November 2016
 
To:
 
30 April 2017
 
Balance of unallotted securities under scheme(s) from previous return:
 
275,420
 
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
0
 
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
 
275,420
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
 
Date: 12 May 2017
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary
 
Period of return:
 
From:
 
1 November 2016
 
To:
 
30 April 2017
 
Balance of unallotted securities under scheme(s) from previous return:
 
100,000
 
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
0
 
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
 
100,000
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
 
Date: 12 May 2017
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
GlaxoSmithKline Savings Related Share Option Scheme
 
Period of return:
 
From:
 
1 November 2016
 
To:
 
30 April 2017
 
Balance of unallotted securities under scheme(s) from previous return:
 
2,742,626
 
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
0
 
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
 
2,742,626 (the GlaxoSmithKline Savings Related Share Option Scheme has now expired. The balance of 2,742,626 un-allotted shares under this Scheme has therefore lapsed)
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
 
Date: 12 May 2017
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
GlaxoSmithKline plc Share Save Plan 2012
 
Period of return:
 
From:
 
1 November 2016
 
To:
 
30 April 2017
 
Balance of unallotted securities under scheme(s) from previous return:
 
239,107
 
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
2,000,000
 
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
603,782
 
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
 
1,635,325
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
 
Date: 12 May 2017
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan
 
Period of return:
 
From:
 
1 November 2016
 
To:
 
30 April 2017
 
Balance of unallotted securities under scheme(s) from previous return:
 
0
 
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
600,000
 
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
399,9291
 
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
 
200,071
 
1 This figure includes an adjustment of +142,952 allotted securities that were allotted under this Scheme but originally debited from the balance for the block listing under the GlaxoSmithKline Share Option Plan - Ordinary Shares.
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
 
 
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

 
 
GlaxoSmithKline plc
 
(Registrant)
 
 
Date: May 12, 2017 
 
 
 
 
By: VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GlaxoSmithKline plc